News

Hot, spicy flavors boost presence in food, beverage market

BY Allison Cerra

ROCKVILLE, Md. — Hot and spicy flavors are on the minds of consumers, according to Packaged Facts and San Francisco-based strategic food and beverage agency CCD Innovation.

In the new report, "Heat & Spice: Culinary Trend Mapping Report," the companies said that these flavors have taken on a new role and are being positioned as a budget-friendly and healthy way to revamp everyday meals. Such flavor trends on the horizon include:

  • Smoked foods, which are moving beyond the traditional fare of such items as bacon;

  • Aleppo peppers (named after a Syrian city), along with Hatch chiles — a species of cultivated chile peppers grown in Hatch, Mexico — are on the verge of becoming all the rage;

  • Fermented chile-based condiment gochujang, a staple in Korean cuisine, is becoming more widely available;

  • Spicy beverages are making a mark in the category;

  • Spices are an important part of being healthy is taking deeper root in the American marketplace. The key to tapping into this shift is creating opportunities for consumers to incorporate healthy spices more extensively into their diets in a tasteful, natural and fresh way, the research said; and

  • The popularity and prevalence of buffalo sauce in all day parts and diets lands it at "mainstream status," Packaged Facts and CCD Innovation said.

"Now more than ever heat and spice can play an upfront strategic role to differentiate familiar products or to attract specific consumer segments and demographics," CCD Innovation CEO Kimberly Egan said. "There are endless ways for restaurant operators and food manufacturers to mix and match flavorful ingredients to enhance the consumer experience and drive powerful innovation."

For more information on "Heat & Spice: Culinary Trend Mapping Report," click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

BioPlus promotes Shelley Moore to lead bleeding disorders program

BY Alaric DeArment

ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday.

BioPlus announced the promotion of Shelley Moore to the position of national director of hemophilia. Moore already has served as head of the company’s bleeding disorders program for Tennessee and has six years’ nursing experience and a career specialty in bleeding disorders.

"BioPlus continues to see patients respond better when they have close contact with our local nurse specialists," BioPlus chief strategic officer Russell Gay said. "The comfort they have with friendly and skilled professionals like Shelley enriches their lives and quietly saves healthcare dollars by reducing hospitalization and drug waste. We all win with Shelley’s approach of high-touch care."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Senate votes down Durbin supplement regulation by almost 4 to 1

BY Michael Johnsen

WASHINGTON — Dietary supplement industry champion Sen. Orrin Hatch, R-Utah, last week led efforts to strike down an amendment that would have dramatically overregulated the dietary supplement industry.

The Senate voted 77-20 to table an amendment to the pending FDA Safety and Innovation Act that was proposed by Dick Durbin, D-Ill. The amendment would have expanded the current registration requirements for anyone involved with the manufacturing, processing, packaging or storage of dietary supplements to register with the Food and Drug Administration. The Durbin Amendment also would have required that all registered facilities would need to submit to the FDA a list of all ingredients for each of the products they sell as well as a copy of every label.

Speaking on the Senate Floor in advance of a vote on the Durbin Amendment, Hatch said the Amendment “is based on the misguided presumption that the current regulatory framework for dietary supplements is flawed and that the FDA lacks authority to regulate these products.”  Hatch added that instead of allowing the FDA to utilize the resources it already has under DSHEA, the Durbin Amendment “serves to punish all responsible companies with its overreaching mandates.”




Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES